AR059902A2 - Complejo de factor viii/vwf o factor viii:c - Google Patents

Complejo de factor viii/vwf o factor viii:c

Info

Publication number
AR059902A2
AR059902A2 ARP070101059A ARP070101059A AR059902A2 AR 059902 A2 AR059902 A2 AR 059902A2 AR P070101059 A ARP070101059 A AR P070101059A AR P070101059 A ARP070101059 A AR P070101059A AR 059902 A2 AR059902 A2 AR 059902A2
Authority
AR
Argentina
Prior art keywords
factor
viii
vwf
factor viii
complex
Prior art date
Application number
ARP070101059A
Other languages
English (en)
Inventor
Arthur Mitterer
Bernhard Fischer
Oyvind L Schonberger
Kathrin Thomas-Urban
Friedrich Dorner
Jonhann Eibl
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3487946&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR059902(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of AR059902A2 publication Critical patent/AR059902A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente se refiere a un complejo de factor VIII/vWF obtenible mediante cromatografía de intercambio cationico. Reivindicacion 1: Un complejo Factor VIII/factor von Willebrand (Factor VIII/vWF) caracterizado porque contiene multímeros de alto peso molecular que tienen una actividad vWF específica de al menos 66 U/mg de proteína y una actividad específica de Factor VIII de al menos 500 U/mg de proteína.
ARP070101059A 1997-02-27 2007-03-15 Complejo de factor viii/vwf o factor viii:c AR059902A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0033897A AT406373B (de) 1997-02-27 1997-02-27 Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie

Publications (1)

Publication Number Publication Date
AR059902A2 true AR059902A2 (es) 2008-05-07

Family

ID=3487946

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP980100835A AR010121A1 (es) 1997-02-27 1998-02-25 MÉTODO DE RECUPERACIoN DE COMPLEJO DE FACTOR VIII/FACTOR DE VON WILLEWBRAND (COMPLEJO DE FACTOR VIII/VWF) MEDIANTE CROMATOGRAFíA DE INTERCAMBIO CATIoNICO.
ARP070101059A AR059902A2 (es) 1997-02-27 2007-03-15 Complejo de factor viii/vwf o factor viii:c

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP980100835A AR010121A1 (es) 1997-02-27 1998-02-25 MÉTODO DE RECUPERACIoN DE COMPLEJO DE FACTOR VIII/FACTOR DE VON WILLEWBRAND (COMPLEJO DE FACTOR VIII/VWF) MEDIANTE CROMATOGRAFíA DE INTERCAMBIO CATIoNICO.

Country Status (11)

Country Link
US (3) US6831159B1 (es)
EP (1) EP0971958B2 (es)
JP (1) JP4250771B2 (es)
AR (2) AR010121A1 (es)
AT (2) AT406373B (es)
AU (1) AU744919B2 (es)
CA (1) CA2282841C (es)
DE (1) DE59814211D1 (es)
ES (1) ES2306471T5 (es)
NO (2) NO324902B1 (es)
WO (1) WO1998038220A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT406373B (de) 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
EP1593388A1 (en) * 2004-05-05 2005-11-09 ZLB Behring GmbH Therapeutic plasma protein-concentrates containing von willebrand factor as high molecular weight multimers
US11197916B2 (en) 2007-12-28 2021-12-14 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
ES2298096B1 (es) 2008-01-08 2009-01-01 Grifols, S.A. Procedimiento para la obtencion de un concentrado de factor von willebrand o del complejo de factor viii/factor von willebrand y utilizacionde los mismos.
TWI508735B (zh) 2008-10-21 2015-11-21 巴克斯特國際公司 凍乾的重組ｖｗｆ調配物
BR112012003802B1 (pt) 2009-08-20 2022-10-25 Takeda Pharmaceutical Company Limited Método para remover um vírus sem envelope lipídico de uma solução
KR101808751B1 (ko) 2009-11-13 2017-12-13 그리폴스 테라퓨틱스 인코포레이티드 폰 빌레브란트 인자(ｖＷＦ)-함유 제제, 및 그와 관련된 방법, 키트 및 용도
EP2598223B1 (en) 2010-07-30 2022-04-06 EMD Millipore Corporation Chromatography media and method
JP6088435B2 (ja) 2010-12-15 2017-03-01 バクスアルタ ゲーエムベーハー 導電率グラディエントを用いる溶出液収集
DK2717905T3 (en) * 2011-06-10 2018-07-02 Baxalta GmbH TREATMENT OF COAGULATION DISEASE BY ADMINISTRATION OF RECOMBINANT VWF
EP2739641B2 (en) 2011-08-02 2020-04-15 Baxalta GmbH Systems and methods to increase protein yield from recombinant manufacturing processes
SG11201408362SA (en) 2012-06-15 2015-01-29 Commw Scient Ind Res Org Production of long chain polyunsaturated fatty acids in plant cells
EP2925777B1 (en) * 2012-11-30 2019-05-01 Centre for Bioseparation Technology-VIT Monolith-based pseudo-bioaffinity purification methods for factor viii and applications thereof
ES2693380T3 (es) 2013-11-08 2018-12-11 Csl Limited Nuevo método para concentrar el factor de von Willebrand o complejos de este
KR102386838B1 (ko) 2013-12-18 2022-04-15 커먼웰쓰 사이언티픽 앤 인더스트리알 리서치 오거니제이션 장쇄 다중불포화 지방산을 포함하는 지질
SG11201610596PA (en) 2014-06-27 2017-01-27 Commw Scient Ind Res Org Lipid comprising docosapentaenoic acid
CN106794389A (zh) 2014-09-02 2017-05-31 Emd密理博公司 具有纳米原纤化表面特征的高表面积纤维介质
CN107001410A (zh) 2014-12-08 2017-08-01 Emd密理博公司 混合床离子交换吸附剂
ES2986574T3 (es) 2017-07-07 2024-11-12 Takeda Pharmaceuticals Co Tratamiento de hemorragia gastrointestinal en pacientes con enfermedad de von willebrand grave mediante la administración de vwf recombinante
WO2020160460A1 (en) 2019-02-01 2020-08-06 Baxalta Incorporated Methods of prophylactic treatment using recombinant vwf (rvwf)
CN114106145B (zh) * 2021-10-22 2023-09-01 山东泰邦生物制品有限公司 一种血源人凝血因子ⅷ/血管性血友病因子复合物生产工艺

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
GB8403473D0 (en) † 1984-02-09 1984-03-14 Special Trustees For St Thomas Purification of factor viii
US5200510A (en) * 1987-06-16 1993-04-06 Zymogenetics, Inc. Method for purifying factor viii:c, von willebrand factor and complexes thereof
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.
NZ237244A (en) 1990-03-02 1992-10-28 Bio Technology General Corp Cloning and production of human von willebrand factor analogues and compositions thereof
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
IT1256622B (it) * 1992-12-04 1995-12-12 Sclavo Spa Processo per l'estrazione del complesso fattore viii-fattore von willebrand (fviii:c-fvw) da plasma umano totale.
CA2159044A1 (en) * 1994-09-26 1996-03-27 Falko-Guenter Falkner Method of quantitating nucleic acids
AT401270B (de) 1994-09-26 1996-07-25 Immuno Ag Verfahren zur quantifizierung von genomischer dna
DE4435392B4 (de) * 1994-10-04 2008-02-07 Immuno Ag Verfahren zur Trennung von vWF in hochmolekularen vWF und niedermolekularen vWF
DE4435485C1 (de) * 1994-10-04 1996-03-21 Immuno Ag Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor
AT403764B (de) * 1996-03-15 1998-05-25 Immuno Ag Stabiler faktor viii/vwf-komplex
CA2251558C (en) 1996-04-12 2005-11-22 Immuno Aktiengesellschaft Highly purified factor viii complex
AT403765B (de) * 1996-04-12 1998-05-25 Immuno Ag Verfahren zur herstellung einer präparation enthaltend einen hochgereinigten komplex
AT405403B (de) * 1997-02-27 1999-08-25 Immuno Ag Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
AT406373B (de) 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie

Also Published As

Publication number Publication date
ES2306471T5 (es) 2012-06-07
US20050239171A1 (en) 2005-10-27
JP4250771B2 (ja) 2009-04-08
AU744919B2 (en) 2002-03-07
NO324902B1 (no) 2007-12-27
CA2282841C (en) 2008-12-02
AR010121A1 (es) 2000-05-17
US6831159B1 (en) 2004-12-14
ES2306471T3 (es) 2008-11-01
EP0971958B2 (de) 2012-02-08
NO994137D0 (no) 1999-08-26
US20020058625A1 (en) 2002-05-16
WO1998038220A1 (de) 1998-09-03
CA2282841A1 (en) 1998-09-03
DE59814211D1 (de) 2008-05-21
NO994137L (no) 1999-08-26
NO20071357L (no) 1999-08-26
US6953837B2 (en) 2005-10-11
AT406373B (de) 2000-04-25
EP0971958B1 (de) 2008-04-09
AU6080698A (en) 1998-09-18
ATA33897A (de) 1999-09-15
EP0971958A1 (de) 2000-01-19
ATE391728T1 (de) 2008-04-15
NO326257B1 (no) 2008-10-27
JP2001517212A (ja) 2001-10-02
US7648958B2 (en) 2010-01-19

Similar Documents

Publication Publication Date Title
AR059902A2 (es) Complejo de factor viii/vwf o factor viii:c
Furlan et al. Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers.
NZ330897A (en) Human trk receptors and neurotropic factor inhibitors
DE69629209D1 (de) Getrocknete zubereitung von bluttfaktoren, enthaltend trehalose
ES2196031T3 (es) Derivados peptidicos terapeutico.
YU53098A (sh) Preparat koncentrovanog antitela
ATE223229T1 (de) Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren
ES2062741T3 (es) Formulaciones nutritivas de alta acidez.
MX9305729A (es) Formulas de proteinas de liberacion sostenida.
DK0503648T3 (da) CD2-bindingsdomæne af lymfocytfunktion-associeret antigen 3
CY1107821T1 (el) Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c
DK0672138T3 (da) Kimære prokoagulante proteiner
NO307702B1 (no) Retinsyre-X-reseptorligander, anvendelse derav og farmasøytiske preparater
EP0695171A1 (en) GONADOTROPINE CONTAINING FREEZER DRIED DROPS
PT523395E (pt) Regioes sero-reactivas na proteina e1 e e2 de hpv 16
ES2181501T3 (es) Composicion cosmetica.
ES2090273T3 (es) Estuche para el dosificado especifico de la angiotensina ii.
BG103968A (en) Pharmaceutical antiviral composition containing glycirricinic acid and at least one protein with antiviral activity
DE69127334D1 (de) Verabreichung von Mitteln
MX9302614A (es) Receptor de glutamato metabotropico humano y compuestos de dna relacionados.
ES2080060T3 (es) Proteinas que tienen actividad de union a interferon-gamma.
DE69032258D1 (de) Antikoagulierende Peptide
DE69806465D1 (de) Eine heteroethynylen-brücke enthaltende bi-aromatische verbindungen und diese enthaltende pharmazeutische und kosmetische zusammensetzungen
FI952738L (fi) Stabiiliproteiini, fosfolipidikoostumuksia ja menetelmiä
NZ231636A (en) Anticoagulant peptides analogus to hirudins' active site

Legal Events

Date Code Title Description
FB Suspension of granting procedure